🇺🇸 FDA
Pipeline program

CD70-targeted CAR-T cells

PBC095

Phase 1 mab active

Quick answer

CD70-targeted CAR-T cells for Renal Cell Carcinoma (RCC) is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Renal Cell Carcinoma (RCC)
Phase
Phase 1
Modality
mab
Status
active

Clinical trials